Prospective Single-Center Cohort Study on HIV Pre-exposure Prophylaxis Reveals Transient but Relevant Elevations in Transaminase Levels in Some Participants Albeit Otherwise High Tolerability-Reference-Cited by-同舟云学术

Prospective Single-Center Cohort Study on HIV Pre-exposure Prophylaxis Reveals Transient but Relevant Elevations in Transaminase Levels in Some Participants Albeit Otherwise High Tolerability

Published:2023-05-01 Issue:1 Volume:93 Page:e1-e3
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Weimann Lukas¹²,Schäfer Guido¹³,Matthews Hanna¹,Florey Maria⁴,Scheiter Robin¹,Hüfner Anja¹,Jordan Sabine¹²,Grenz Marc⁵,Schmiedel Stefan¹²,Schulze zur Wiesch Julian²³,Degen Olaf¹,Koch Till¹²⁶

Affiliation:

1. Infectious Diseases Clinic, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;

2. First Department of Medicine, Division of Infectious Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;

3. German Centre for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Germany;

4. Pharmacy of the University Medical Center Hamburg-Eppendorf, Hamburg, Germany;

5. ICH Study Center GmbH & Co KG, Hamburg, Germany; and

6. Hein & Fiete - Der schwule Checkpoint, Hamburg, Germany.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference6 articles.

1. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial;McCormack;Lancet,2016

2. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study;Molina;Lancet HIV.,2017

3. An overview of tenofovir and renal disease for the HIV-treating clinician;Venter;South Afr J HIV Med.,2018

4. Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials;Gupta;Aids,2019

5. Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors;Dieterich;Clin Infect Dis.,2004